Business · 23/07/2012Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Cardiovascular and Renal Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of its Cardiovascular and Renal Drugs Advisory Committee to provide advice on FDA's regulatory issues, and the meeting will be open to the public.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →